Skip to main content
[Preprint]. 2021 Dec 22:2021.04.13.21255438. Originally published 2021 Apr 20. [Version 2] doi: 10.1101/2021.04.13.21255438

Table 2.

Outcomes in NSAID cohort and propensity-matched control cohort. Number of patients and percent of cohort for each outcome are shown. AKI: acute kidney injury; ECMO: extracorporeal membrane oxygenation.

NSAID Control
COVID-19 severity
Moderate 18023 (91.3%) 16972 (86%)
Severe 776 (3.9%) 1047 (5.3%)
Dead 947 (4.8%) 1727 (8.8%)
Invasive ventilation 1150 (5.8%) 1867 (9.5%)
AKI 1729 (8.8%) 2437 (12.3%)
ECMO 54 (0.27%) 109 (0.55%)